Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Today's Top SOA Links


Medpace, Inc. Acquires MediTech Strategic Consultants B.V., a European-Based Contract Research Organization (CRO) Specializing in Medical Device

CINCINNATI, OH -- (Marketwire) -- 11/20/12 -- Medpace, a privately held, global, full-service contract research organization (CRO) announced that it has acquired MediTech Strategic Consultants B.V. (MediTech), a European CRO dedicated to medical device clinical trials and services related to development and commercialization of medical devices.

MediTech joins Medpace as a strategic European acquisition, expanding Medpace's European device capabilities both in the development of trial designs and regulatory strategies towards CE Mark, in addition to the conduct of clinical trials and authorized representative and quality system support towards ISO 13485. This acquisition, combined with Medpace's existing medical device division, provides a unique global solution for medical device development, allowing seamless support through all stages of the medical device lifecycle.

MediTech was founded in 2000 by Carla Kikken-Jussen, President & CEO, an industry expert with over 25 years of experience in the medical device industry covering medical device clinical research and European regulatory affairs. MediTech has supported clinical trials on wide variety of medical devices including therapeutic areas such as ophthalmology, cardiovascular, gastroenterology, orthopedics, and pulmonology medical devices. Ms. Kikken-Jussen will continue to lead MediTech with her team members, bringing extensive experience to Medpace.

"I am pleased to welcome Carla Kikken-Jussen and the MediTech team to Medpace," said Dr. August Troendle, President and CEO, Medpace. "MediTech's expertise complements and broadens our global medical device service offering. MediTech is well respected in both Europe and the US and this strategic acquisition fully supports Medpace's growth and provides our sponsors a wide range of regulatory and clinical expertise across North America and Europe along with expanded operational capacity."

ABOUT MEDPACE

Medpace is a leading global full-service clinical research organization providing Phase I-IV core development services for drug, biologic, and device programs. With medical and regulatory expertise in multiple therapeutic specialties, Medpace has assembled the industry's most experienced and therapeutically focused teams to execute at every level of the company's operations, providing complete and seamless drug development services. Medpace creates strategic partnerships with pharmaceutical and biotechnology companies to provide the most efficient and cost-effective path to drug development -- from program planning and execution to product approval.

With more than 1200 employees and clinical trial experience in over 40 countries, Medpace has the global reach and capability to conduct studies and navigate regulatory requirements worldwide. In addition to Phase II-IV development services, Medpace provides Phase I / IIA clinical services from Medpace Clinical Pharmacology, central laboratory and therapeutically specialized testing from Medpace Reference Laboratories, complete bioanalytical services in all stages of drug development from Medpace Bioanalytical Laboratories, centralized imaging core laboratory management and reading from Imagepace, and medical device development from Medpace Medical Device.

Visit the Medpace website at www.medpace.com

ABOUT MEDITECH STRATEGIC CONSULTANTS B.V.

MediTech Strategic Consultants B.V. (MediTech) is a full service international Contract Research Organization (CRO) focused on Clinical, Regulatory, Clinical Specialist and Quality Consulting and Authorized Representative services with a staff of more than 40 highly qualified team members in the areas of ophthalmology, cardiovascular, gastroenterology, orthopedics, and pulmonology.

MediTech's team member's extensive clinical, regulatory and quality experience is complemented by multilingual and cross cultural fluency. The multinational staff are based in The Netherlands HQ office with additional professionals in the Czech Republic, Israel and Poland who offer comprehensive support services to meet our client's needs for clinical trials conducted throughout the European Union and Israel, Norway, Switzerland and Turkey. The MediTech team can provide all the clinical, regulatory and quality guidance and project support you require.

Visit the MediTech B.V. website at: www.meditech.nl

About Marketwired .
Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Web 2.0 Latest News
For retailers everywhere, it’s a challenging new day. Security threats are a constant – both inside their four walls and out. The big security breaches we hear about on the news; the smaller ones sometimes not. But their impact remains costly to us all. The need for mobility, rapidly e...
I write and study often on the subject of digital transformation - the digital transformation of industries, markets, products, business models, etc. In brief, digital transformation is about the impact that collected and analyzed data can have when used to enhance business processes ...
I had the privilege of attending a mobile security event this week and speaking with many experts on the matter. I am not a mobile security expert, so my role was to speak on mobile strategies and trends and to learn as much as I could. What did I learn? I learned the difference b...
General Electric (GE) has been a household name for more than a century, thanks in large part to its role in making households easier to run. Starting with the light bulb invented by its founder, Thomas Edison, GE has been selling devices (“things”) to consumers throughout its 122-year...
It's time to condense all I've seen, heard, and learned about the IoT into a fun, easy-to-remember guide. Without further ado, here are Five (5) Things About the Internet of Things: 1. It's the end-state of Moore's Law. It's easy enough to debunk the IoT as “nothing new.” After all,...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE